TELA Bio, Inc. (TELA) shareholders
Close on Nov 19, 2026Market cap $32.63MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| EW Healthcare Partners Fund 2-GP, L.P. Joint filing with EW Healthcare Partners Fund 2-UGP, LLC (17.23%), Ew Healthcare Partners Fund 2-A, L.P. (10.46%) and 1 more | 7,714,709 | 17.23% | 13D (active) | Jun 9, 2026 |
| EW Healthcare Partners Fund 2 GP, L.P. Joint filing with EW Healthcare Partners Fund 2-UGP, LLC (17.32%), Ew Healthcare Partners Fund 2-A, L.P. (10.52%) and 1 more | 7,714,709 | 17.32% | 13G (passive) amendment | Nov 17, 2025 |
| Wilmot B. Harkey Joint filing with Nantahala Capital Management, LLC (12.94%), Daniel Mack (12.94%) | 5,794,114 | 12.94% | 13G (passive) amendment | Jun 30, 2026 |
| Daniel Mack Joint filing with Nantahala Capital Management, LLC (12.90%), Wilmot B. Harkey (12.90%) | 5,111,588 | 12.90% | 13G (passive) amendment | Apr 30, 2025 |
| Nantahala Capital Management, LLC Joint filing with Wilmot B. Harkey (9.99%), Daniel Mack (9.99%) | 3,974,326 | 9.99% | 13G (passive) amendment | Dec 31, 2024 |
| North Run - Due North Partners, LP Joint filing with North Run Capital, LP (9.30%), North Run Advisors, LLC (9.30%) and 4 more | 3,682,489 | 9.30% | 13G (passive) amendment | Mar 31, 2025 |
| Devesh S. Gandhi Joint filing with SilverArc Capital Management, LLC (7.80%) | 3,065,649 | 7.80% | 13G (passive) | Dec 31, 2024 |
| Lytton, Laurence W. | 2,442,341 | 5.50% | 13G (passive) amendment | Mar 31, 2026 |
| Stonepine Capital Management, LLC Joint filing with Stonepine Capital, L.P. (6.00%), Stonepine GP, LLC (6.00%) and 1 more | 2,353,099 | 6.00% | 13G (passive) amendment | Dec 31, 2024 |
| North Run GP, LP Joint filing with North Run Capital, LP (5.00%), North Run Advisors, LLC (5.00%) and 4 more | 1,982,489 | 5.00% | 13G (passive) | Jan 24, 2025 |
| Grow Funds, LLC. | – | – | 13G (passive) amendment | Sep 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of TELA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 11,788,228 | 26.26% | $8.84M | +6,644,114 | 0.15% |
| Essex Woodlands Management, Inc. | 7,714,709 | 17.18% | $5.79M | – | 2.28% |
| Stonepine Capital Management, LLC | 2,662,427 | 5.93% | $2.00M | +45,175 | 1.13% |
| Silverarc Capital Management, LLC | 2,137,201 | 4.76% | $1.60M | −122,111 | 0.17% |
| Vanguard Capital Management LLC | 1,568,218 | 3.49% | $1.18M | +27,594 | 0.00% |
| DAFNA Capital Management LLC | 1,441,029 | 3.21% | $1.08M | – | 0.21% |
| Perkins Capital Management Inc | 1,375,042 | 3.06% | $1.03M | −43,286 | 0.78% |
| Sio Capital Management, LLC | 636,300 | 1.42% | $477.23K | – | 0.08% |
| WealthTrust Axiom LLC | 457,734 | 1.02% | $343.30K | +80,796 | 0.08% |
| Geode Capital Management, LLC | 389,223 | 0.87% | $291.95K | −65,836 | 0.00% |
| BlackRock, Inc. | 374,516 | 0.83% | $280.89K | −91,298 | 0.00% |
| Vanguard Fiduciary Trust Co | 213,138 | 0.47% | $159.85K | +1,476 | 0.00% |
| Up Strategic Wealth Investment Advisors LLC | 99,888 | 0.22% | $91.40K | – | 0.05% |
| Embree Financial Group | 90,906 | 0.20% | $68.18K | −27,272 | 0.01% |
| Northern Trust Corp | 74,790 | 0.17% | $56.09K | −99,608 | 0.00% |
| Raymond James Financial Inc | 67,700 | 0.15% | $50.78K | +18,000 | 0.00% |
| State Street Corp | 63,383 | 0.14% | $47.54K | – | 0.00% |
| Renaissance Technologies LLC | 58,100 | 0.13% | $43.58K | +5,500 | 0.00% |
| PNC Financial Services Group, Inc. | 53,612 | 0.12% | $40.21K | – | 0.00% |
| Destiny Wealth Partners, LLC | 52,500 | 0.12% | $38.32K | – | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 45 | 32M | 70.5% | 10 / 12 | 10 / 1 | 7M | 2M |
| Q1 2026 | 36 | 27M | 59.9% | 4 / 14 | 4 / 9 | 2M | 1M |
| Q4 2025 | 42 | 28M | 61.4% | 7 / 12 | 8 / 5 | 6M | 2M |
| Q3 2025 | 40 | 24M | 52.5% | 1 / 10 | 10 / 7 | 1M | 0M |
| Q2 2025 | 46 | 23M | 52.3% | 8 / 11 | 10 / 12 | 1M | 3M |
| Q1 2025 | 50 | 25M | 54.8% | 14 / 10 | 16 / 11 | 1M | 4M |
| Q4 2024 | 47 | 27M | 60.5% | 13 / 21 | 6 / 15 | 13M | 4M |
| Q3 2024 | 49 | 18M | 40.1% | 9 / 11 | 21 / 27 | 3M | 7M |
| Q2 2024 | 68 | 22M | 49.7% | 24 / 15 | 23 / 14 | 7M | 5M |
| Q1 2024 | 58 | 21M | 46.3% | 9 / 20 | 21 / 10 | 2M | 3M |
| Q4 2023 | 60 | 22M | 49.4% | 5 / 28 | 19 / 11 | 4M | 3M |
| Q3 2023 | 67 | 22M | 48.7% | 3 / 29 | 20 / 3 | 2M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
14 funds held TELA in Q1 2026, 71% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of TELA | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,149,678 | 2.56% | $862.26K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 389,470 | 0.87% | $292.10K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 216,620 | 0.48% | $210.12K | 0.00% | May 31, 2026 |
| Jacob Small Cap Growth Fund | 81,000 | 0.18% | $78.57K | 0.95% | May 31, 2026 |
| Jacob Discovery Fund | 79,775 | 0.18% | $77.38K | 0.48% | May 31, 2026 |
| Fidelity Total Market Index Fund | 66,813 | 0.15% | $64.81K | 0.00% | May 31, 2026 |
| Perkins Discovery Fund | 64,000 | 0.14% | $39.68K | 0.68% | Mar 31, 2026 |
| Fidelity Series Total Market Index Fund | 55,409 | 0.12% | $53.75K | 0.00% | May 31, 2026 |
| Vanguard Balanced Index Fund | 29,070 | 0.06% | $21.80K | 0.00% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 18,634 | 0.04% | $18.07K | 0.00% | May 31, 2026 |
| Knights of Columbus U.S. ALL CAP INDEX FUND | 230 | 0.00% | $168 | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Heather C. Getz | Chief Executive Officer, Director | 532,500 | 1.19% | Aug 19, 2026 |
| Antony Koblish | Chief Executive Officer, Director | 586,210 | 1.31% | Feb 24, 2026 |
| Howard N. Langstein | Chief Medical Officer | 71,347 | 0.16% | Mar 11, 2026 |
| Jeffrey Blizard | President | 205,125 | 0.46% | Feb 24, 2026 |
| Paul Talmo | Chief Technology Officer | 173,436 | 0.39% | Feb 24, 2026 |
| Gregory A. Firestone | Chief Business Officer | 139,307 | 0.31% | Feb 24, 2026 |
| Megan Smeykal | Chief Accounting Officer | 66,873 | 0.15% | Feb 24, 2026 |
| Roberto Cuca | COO and CFO | 257,377 | 0.57% | Feb 24, 2026 |
| Joseph H. Capper | Director | 199,628 | 0.44% | Oct 19, 2026 |
| William J. Plovanic | Director | 60,619 | 0.14% | Oct 19, 2026 |
| Guido J. Neels | Director | 23,600 | 0.05% | Jun 11, 2026 |
| Betty Jo Rocchio | Director | 23,600 | 0.05% | Jun 11, 2026 |
| Guy P. Nohra | Director | 23,600 | 0.05% | Jun 11, 2026 |
| Paul Thomas | Director | 23,600 | 0.05% | Jun 11, 2026 |
| Vincent J. Burgess | Director | 23,330 | 0.05% | May 30, 2025 |
| Federica F. O'Brien | Director | 18,470 | 0.04% | May 30, 2025 |
| Douglas G. Evans | Director | 18,470 | 0.04% | May 30, 2025 |
| Kurt Azarbarzin | Director | 532,951 | 1.19% | May 30, 2025 |
| Lisa N. Colleran | Director | 18,470 | 0.04% | May 30, 2025 |
| Ew Healthcare Partners Fund 2-A, L.P. | 10% owner | 4,699,940 | 10.47% | Nov 17, 2025 |
| EW Healthcare Partners Fund 2-UGP, LLC | 10% owner | 11,305,418 | 25.18% | Nov 17, 2025 |
| EW Healthcare Partners Fund 2 GP, L.P. | 10% owner | 3,610,709 | 8.04% | Nov 17, 2025 |
| Ew Healthcare Partners Fund 2, L.P. | 10% owner | 4,376,149 | 9.75% | Nov 17, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| William J. Plovanic Director | Oct 15, 2026 | Award | +16,089 | $1.01 | $16.25K | 60,619 |
| Joseph H. Capper Director | Oct 15, 2026 | Award | +19,801 | $1.01 | $20.00K | 199,628 |
| Joseph H. Capper Director | Sep 17, 2026 | Buy | +25,000 | $1.22 | $30.50K | 179,827 |
| Joseph H. Capper Director | Sep 16, 2026 | Buy | +50,000 | $1.17 | $58.50K | 154,827 |
| Joseph H. Capper Director | Sep 15, 2026 | Buy | +50,000 | $1.06 | $53.00K | 104,827 |
| Joseph H. Capper Director | Sep 14, 2026 | Buy | +25,000 | $1.02 | $25.50K | 54,827 |
| Heather C. Getz Chief Executive Officer, Director | Aug 17, 2026 | Buy | +12,500 | $0.66 | $8.25K | 532,500 |
| Heather C. Getz Chief Executive Officer, Director | Aug 14, 2026 | Buy | +15,000 | $0.70 | $10.50K | 520,000 |
| Heather C. Getz Chief Executive Officer, Director | Aug 3, 2026 | Award | +500,000 | – | – | 505,000 |
| William J. Plovanic Director | Jul 15, 2026 | Award | +20,930 | $0.79 | $16.53K | 44,530 |
| Joseph H. Capper Director | Jul 15, 2026 | Award | +6,227 | $0.79 | $4.92K | 29,827 |
| William J. Plovanic Director | Jun 9, 2026 | Award | +11,675 | – | – | 23,600 |
| Guy P. Nohra Director | Jun 9, 2026 | Award | +11,675 | – | – | 23,600 |
| Guy P. Nohra Director | Jun 9, 2026 | Award | +11,925 | – | – | 11,925 |
| Joseph H. Capper Director | Jun 9, 2026 | Award | +11,675 | – | – | 23,600 |
| Joseph H. Capper Director | Jun 9, 2026 | Award | +11,925 | – | – | 11,925 |
| Guido J. Neels Director | Jun 9, 2026 | Award | +11,675 | – | – | 23,600 |
| Guido J. Neels Director | Jun 9, 2026 | Award | +11,925 | – | – | 11,925 |
| Paul Thomas Director | Jun 9, 2026 | Award | +11,675 | – | – | 23,600 |
| Paul Thomas Director | Jun 9, 2026 | Award | +11,925 | – | – | 11,925 |
| Betty Jo Rocchio Director | Jun 9, 2026 | Award | +11,675 | – | – | 23,600 |
| Antony Koblish Chief Executive Officer, Director | Feb 24, 2026 | Tax withholding | −3,900 | $0.79 | $3.08K | 586,210 |
| Paul Talmo Chief Technology Officer | Feb 23, 2026 | Tax withholding | −4,061 | $0.77 | $3.13K | 173,436 |
| Megan Smeykal Chief Accounting Officer | Feb 23, 2026 | Tax withholding | −423 | $0.77 | $326 | 66,873 |
| Antony Koblish Chief Executive Officer, Director | Feb 23, 2026 | Tax withholding | −11,631 | $0.77 | $8.96K | 741,985 |
| Roberto Cuca COO and CFO | Feb 23, 2026 | Tax withholding | −5,234 | $0.77 | $4.03K | 257,377 |
| Gregory A. Firestone Chief Business Officer | Feb 23, 2026 | Tax withholding | −1,352 | $0.77 | $1.04K | 139,307 |
| Paul Talmo Chief Technology Officer | Feb 21, 2026 | Tax withholding | −3,385 | $0.72 | $2.44K | 177,497 |
| Megan Smeykal Chief Accounting Officer | Feb 21, 2026 | Tax withholding | −1,590 | $0.72 | $1.14K | 67,296 |
| Antony Koblish Chief Executive Officer, Director | Feb 21, 2026 | Tax withholding | −12,494 | $0.72 | $9.00K | 753,616 |
| Roberto Cuca COO and CFO | Feb 21, 2026 | Tax withholding | −4,780 | $0.72 | $3.44K | 262,611 |
| Gregory A. Firestone Chief Business Officer | Feb 21, 2026 | Tax withholding | −4,189 | $0.72 | $3.02K | 140,659 |
| Jeffrey Blizard President | Feb 20, 2026 | Award | +86,000 | – | – | 205,125 |
| Paul Talmo Chief Technology Officer | Feb 20, 2026 | Award | +57,000 | – | – | 180,882 |
| Antony Koblish Chief Executive Officer, Director | Feb 20, 2026 | Award | +176,000 | – | – | 766,110 |
| Roberto Cuca COO and CFO | Feb 20, 2026 | Award | +57,000 | – | – | 267,391 |
| Gregory A. Firestone Chief Business Officer | Feb 20, 2026 | Award | +37,000 | – | – | 144,848 |
| Megan Smeykal Chief Accounting Officer | Feb 19, 2026 | Tax withholding | −795 | $0.80 | $636 | 68,886 |
| Megan Smeykal Chief Accounting Officer | Feb 18, 2026 | Award | +32,850 | – | – | 69,681 |
| EW Healthcare Partners Fund 2-UGP, LLC 10% owner | Nov 17, 2025 | Buy | +3,604,000 | $1.11 | $4.00M | 7,714,709 |
| William J. Plovanic Director | Oct 31, 2025 | Award | +11,925 | – | – | 11,925 |
| Betty Jo Rocchio Director | Oct 9, 2025 | Award | +11,925 | – | – | 11,925 |
| Gregory A. Firestone Chief Commercial Officer | Aug 3, 2025 | Tax withholding | −1,093 | $1.86 | $2.03K | 106,790 |
| Jeffrey Blizard President | Jun 2, 2025 | Award | +104,800 | – | – | 119,125 |
| Kurt Azarbarzin Director | May 28, 2025 | Award | +7,950 | – | – | 18,470 |
| Jeffrey Blizard Director | May 28, 2025 | Award | +7,950 | – | – | 14,325 |
| Lisa N. Colleran Director | May 28, 2025 | Award | +7,950 | – | – | 18,470 |
| Vincent J. Burgess Director | May 28, 2025 | Award | +7,950 | – | – | 23,330 |
| Douglas G. Evans Director | May 28, 2025 | Award | +7,950 | – | – | 18,470 |
| Federica F. O'Brien Director | May 28, 2025 | Award | +7,950 | – | – | 18,470 |
| Antony Koblish Chief Executive Officer, Director | Mar 31, 2025 | Tax withholding | −384 | $1.22 | $468 | 590,110 |
| Gregory A. Firestone Chief Commercial Officer | Mar 31, 2025 | Tax withholding | −119 | $1.22 | $145 | 106,804 |
| Paul Talmo Chief Technology Officer | Mar 31, 2025 | Tax withholding | −190 | $1.22 | $232 | 123,882 |
| Megan Smeykal Chief Accounting Officer | Mar 31, 2025 | Tax withholding | −96 | $1.22 | $117 | 36,831 |
| Paul Talmo Chief Technology Officer | Feb 24, 2025 | Tax withholding | −1,049 | $2.65 | $2.78K | 124,072 |
| Antony Koblish Chief Executive Officer, Director | Feb 24, 2025 | Tax withholding | −5,772 | $2.65 | $15.30K | 590,494 |
| Megan Smeykal Chief Accounting Officer | Feb 24, 2025 | Tax withholding | −539 | $2.65 | $1.43K | 36,927 |
| Gregory A. Firestone Chief Commercial Officer | Feb 24, 2025 | Tax withholding | −240 | $2.65 | $636 | 106,923 |
| Paul Talmo Chief Technology Officer | Feb 23, 2025 | Tax withholding | −4,061 | $2.72 | $11.05K | 125,121 |
| Antony Koblish Chief Executive Officer, Director | Feb 23, 2025 | Tax withholding | −11,631 | $2.72 | $31.64K | 596,266 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of TELA Bio's stock actually held short. Settlement fails (shares not delivered on time) peaked at 29,746 shares on Aug 28, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| OrbiMed Private Investments IV, LP Shareholder | Jun 28, 2024 | 428,386 | $2.20M | Jun 28, 2024 | Private Placement |
| OrbiMed Private Investments IV, LP Shareholder | Apr 19, 2023 | 192,000 | $2.04M | Apr 19, 2023 | Private placement |
See a number that looks wrong?